During the past decade, Chattanooga Research and Medicine (CHARM) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chattanooga Research and Medicine (CHARM)" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chattanooga Research and Medicine (CHARM)" are "Cardiovascular Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Dyslipidemia" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Chattanooga Research and Medicine (CHARM)" in a lesser frequency.

Most popular intervention types in "Chattanooga Research and Medicine (CHARM)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dulaglutide" (1 trials), "K-877" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chattanooga Research and Medicine (CHARM)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Chattanooga Research and Medicine (CHARM)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chattanooga Research and Medicine (CHARM), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chattanooga Research and Medicine (CHARM), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".